|
J Biol Chem, Vol. 273, Issue 36, 22962-22968, September 4, 1998
Activation of the Janus Kinase/Signal Transducer and Activator of
Transcription Pathway by Osmotic Shock*
Petros
Gatsios ,
Lara
Terstegen §,
Freimut
Schliess¶,
Dieter
Häussinger¶,
Ian M.
Kerr ,
Peter C.
Heinrich , and
Lutz
Graeve **
From the Institute of Biochemistry,
Rheinisch-Westfälische Technische Hochschule Aachen, 52057 Aachen, Germany, ¶ Medizinische Klinik der
Heinrich-Heine-Universität, 40225 Düsseldorf, Germany,
§ Interdisziplinäres Zentrum für Klinische
Forschung (BIOMAT), Rheinisch-Westfälische Technische Hochschule
Aachen, 52057 Aachen, Germany, and the Imperial Cancer Research
Fund, 44 Lincoln's Inn Field, London WC2A 3PX, United Kingdom
 |
ABSTRACT |
Numerous cytokines, growth, and differentiation
factors elicit their intracellular responses via Janus tyrosine kinases
(Jaks) and transcription factors of the STAT (signal transducer and
activator of transcription) family. Additionally, environmental stress
(UV light, heat, aniso-osmolarity, and radicals) has recently been shown to activate intracellular signaling cascades such as the stress-activated protein kinases and nuclear factor- B. In this study, we demonstrate that in different cell lines a particular stress,
namely hyperosmolarity, results in tyrosine phosphorylation of the
Janus kinases Jak1, Jak2, and Tyk2 and in the activation of STAT1
and/or STAT3. Both transcription factors are phosphorylated at a
specific tyrosine residue and translocation to the nucleus was
demonstrated by the use of a STAT3/green fluorescent protein fusion
protein. A prominent role for Jak1 in the activation of STATs by
hypertonicity was demonstrated by the use of Jak-deficient cell lines.
Stress-activated STAT1 and STAT3 transactivate a reporter gene
containing the acute-phase response element of the rat
2-macroglobulin promoter. Experiments using a
diffusible solute suggest that not the increase in intracellular
osmolarity but the resultant cell shrinkage is the trigger for Jak/STAT
activation.
 |
INTRODUCTION |
Growth factors and cytokines activate intracellular signal
transduction pathways, which ultimately lead to proliferation, differentiation, and/or altered gene expression. In recent years, it
has become evident that physicochemical stress such as UV irradiation, heat, free radicals, hypoxia, and aniso-osmolarity can also trigger some of these signal transduction cascades and thereby change cell
function. Thus, it was demonstrated that UV irradiation and H2O2 activate transcription of the immediate
early gene c-jun via a pathway involving Src tyrosine
kinases, Ras, Raf-1, and the c-Jun N-terminal kinase
(JNK)1 (1-3). Additionally,
transcription factor NF- B is activated by UV irradiation, oxygen
radicals, and hypoxia (4-6). Alterations in cellular hydration induced
by either aniso-osmotic environments or under the influence of
hormones, oxidative stress, or cumulative substrate uptake represent
independent signals, which modulate cell function (for reviews, see
Refs. 7 and 8). In some cells, hypo-osmolarity induced elevation of
intracellular calcium concentrations (9, 10) and led to a rapid
activation of the mitogen-activated protein kinases Erk-1 and Erk-2
(11-14). In contrast, hyper-osmotic stress mainly triggered activation
of the JNKs and p38, the mammalian homologue to the yeast
mitogen-activated protein kinase high osmolarity glycerol response 1 (HOG1) (15-17).
Recently, it was demonstrated that UV light and high osmolarity induce
clustering and internalization of receptors for epidermal growth factor
(EGF), interleukin-1 (IL-1), and tumor necrosis factor ,
finally resulting in an activation of JNK-1 (18).
Another important signal transduction cascade, the Jak/STAT pathway, is
activated by numerous cytokines (19), growth (20-24), and
differentiation factors (25-29). After ligand-induced dimerization of
receptor subunits, cytoplasmic tyrosine kinases of the Jak family
become autophosphorylated and thereby activated. Substrates for these
kinases are the receptors themselves and transcription factors of the
STAT family, which dimerize, translocate to the nucleus, and bind to
enhancers within the regulatory regions of target genes resulting in
their increased transcription (19, 30).
In this study, we have raised the question whether osmotic shock leads
to an activation of the Jak/STAT pathway. We show that in different
cell lines hypertonic treatment results in a rapid phosphorylation of
Jak1, Jak2, and Tyk2 and in the activation of STAT1 and/or STAT3.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Restriction enzymes and T4-DNA ligase were
purchased from Boehringer Mannheim (Mannheim, Germany).
Oligonucleotides were purchased from MWG Biotech (Ebersberg, Germany).
Dulbecco's modified Eagle's medium (DMEM), DMEM/F-12 mix, and RPMI
1640 were from Life Technologies, Inc. (Eggenstein, Germany), and fetal
calf serum was from Seromed (Berlin, Germany). Recombinant human IL-6
and soluble IL-6 receptor gp80 (sgp80) were prepared as described (31,
32). Reporter gene constructs p7xcore/tk/CAT and ptk/CAT were kindly
provided by Dr. F. Horn (RWTH Aachen, Germany).
Cell Culture--
COS-7, HeLa, 2fTGH parental, and mutant cells
(U4A, 2A, and U1A) (33) were grown in DMEM; HepG2 cells in DMEM/F-12
mix; and rat mesangial cells (RMC) (34) in RPMI 1640 at 5%
CO2 in a water-saturated atmosphere. All cell culture media
were supplemented with 10% fetal calf serum, streptomycin (100 mg/liter), and penicillin (60 mg/liter). HepG2 cells were
serum-deprived for 18 h before stimulation with sorbitol or
IL-6.
Stimulation of Cells--
Cells grown in a 100-mm dish to 80%
confluence were stimulated with sorbitol, sodium chloride, urea, or
IL-6 (± sgp80) as indicated in the figure legends. Nuclear extracts
were prepared as described by Andrews and Faller (35). The protein
concentration was determined with a Bio-Rad protein assay.
Electrophoretic Mobility Shift Assay (EMSA)--
EMSAs were
performed as described previously (36) using a double-stranded
32P-labeled mutated m67SIE oligonucleotide from the
c-fos promotor (m67SIE: 5'-GAT CCG GGA GGG ATT TAC GGG GAA
ATG CTG-3') (37). The protein-DNA complexes were separated on a 4.5%
polyacrylamide gel containing 7.5% glycerol in 0.25-fold TBE at 20 V/cm for 4 h. Gels were fixed in 10% methanol, 10% acetic acid,
and 80% water for 1 h, dried, and autoradiographed.
Immunoprecipitation--
Cells were washed twice with PBS and
solubilized in 1 ml of lysis buffer (1% Brij 96, 20 mM
Tris/HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA) for
30 min at 4 °C. Nuclei were removed by centrifugation for 10 min at
12.000 × g. The supernatants were incubated with 1 µg of anti-Jak1 (polyclonal), anti-Jak2 (polyclonal), anti-Tyk2 (monoclonal), or anti-gp130 (B-T12; monoclonal) antibodies,
respectively, for a minimum of 8 h at 4 °C. After antibody
incubation, the lysates were treated with protein A-Sepharose (5 mg/ml
in lysis buffer) for 2 h at 4 °C. When monoclonal antibodies
were used, rabbit anti-mouse IgG was bound to the protein A-Sepharose
beads. After centrifugation of the immunocomplexes, the Sepharose beads
were washed four times with wash buffer (0.1% Brij 96, 20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA). The samples were boiled in gel electrophoresis
sample buffer, and the precipitated proteins were separated on a
SDS-polyacrylamide (10%) gel.
Western Blotting and Immunodetection--
The
electrophoretically separated proteins were transferred onto
polyvinylidene difluoride (PVDF) membranes by the semidry Western
blotting method. Nonspecific binding was blocked with 10% bovine serum
albumin in TBS-N (20 mM Tris/HCl, pH 7.4, 137 mM NaCl, 0.1% Nonidet P-40) for 15 min. The blots were
incubated with primary antibodies at 1/1000 dilution in TBS-N for
1 h. After extensive rinsing with TBS-N, blots were incubated with
secondary antibodies, goat anti-rabbit IgG or goat anti-mouse IgG,
conjugated to horseradish peroxidase for 1 h. After further
rinsing in TBS-N, the immunoblots were developed with the enhanced
chemiluminescence (ECL; Amersham Pharmacia Biotech) system following
the manufacturer's instructions. The following primary antibodies were
used in Western blotting experiments: anti-phosphotyrosine mouse
monoclonal antibody (4G10; Upstate Biotechnology); anti-Jak1 and -Jak2
rabbit polyclonal antibodies (kindly provided by Dr. Ziemiecki, Bern);
anti-Tyk2 (Upstate Biotechnology); anti-gp130 mouse monoclonal antibody (B-P4); phosphospecific STAT1 (Tyr-701), and STAT3 (Tyr-705) rabbit polyclonal antibody (New England Biolabs). Phosphospecific STAT1 antibody (Tyr-701) detects STAT1 only when phosphorylated at Tyr-701. Phosphospecific STAT3 antibody (Tyr-705) detects STAT3 only when phosphorylated at Tyr-705.
Transient Transfections--
HepG2 cells were grown on 60-mm
dishes to 30% confluence and transfected in Dulbecco's modified
Eagle's medium supplemented with 10% fetal calf serum, using standard
calcium phosphate precipitates, with 7.5 µg of reporter construct
plasmid DNA and 2.5 µg of internal control plasmid DNA pCH110
(Amersham Pharmacia Biotech). Cells were incubated with precipitate for
18 h, washed twice with PBS, and media changed for additional
6 h. Cells were then stimulated for 3 h and protein extracts
were prepared for CAT and -galactosidase assays as described
(38).
Construction of the STAT3/Green Fluorescent Protein (GFP)
Chimera--
Green fluorescent protein cDNA was introduced into
the pSBC-2 mammalian expression vector via the
EcoRI/HindIII restriction sites. An
oligonucleotide (5'-GGC CGC GGA GAT CTG GC-3') containing the
BglII restriction site was cloned into the
NotI/EcoRI sites of pSBC-2-GFP expression vector.
A BglII site was introduced at the stop-codon of STAT3
cDNA via polymerase chain reaction. The STAT3 cDNA was
subcloned into the pSBC-2-GFP expression vector via
NotI/BglII restriction sites resulting in a
fusion protein of STAT3 with GFP at its C terminus
(pSBC-2-STAT3-GFP).
HeLa Cell Transfections and Fluorescence Studies--
HeLa cells
were transfected using the DNA/calcium phosphate precipitation method.
Approximately 105 cells were seeded on coverslips and
cultured for 48 h. Cells were washed twice with PBS and fixed with
2% paraformaldehyde, and coverslips were mounted on slides with
MowiolTM 4-88 (Calbiochem Corp., La Jolla, CA). Cells were
analyzed using a Nikon Eclipse E600TM fluorescence
microscope at a magnification of ×400.
 |
RESULTS |
Activation of STAT Factors by Osmotic Shock in Different Cell
Lines--
In order to study whether hypertonicity (osmotic shock)
results in an activation of the Jak/STAT signaling pathway, human hepatoma HepG2 cells were serum-deprived for 18 h and subsequently incubated with serum-free medium containing 600 mM sorbitol
for 15 min. Such a treatment was recently shown to activate the JNK cascade in HeLa cells (18). Nuclear extracts were incubated with a
32P-labeled oligonucleotide specific for STAT1 and STAT3
(37, 39) and analyzed in an EMSA. Upon sorbitol treatment a prominent band was detected in the gel shift assay that migrated at a position typical for the STAT3 homodimer (Fig.
1A, left
panel). When the same experiment was repeated in the
SV40-transformed simian kidney cell line COS-7, a prominent band
migrating somewhat faster was observed (Fig. 1A,
middle panel). This band represents the STAT1 homodimer, which is also the major STAT form activated in these cells
upon stimulation with IL-6 and the soluble form of the IL-6 receptor
(sgp80) (40). A rat mesangial cell line (RMC) showed two bands after
osmotic shock, a STAT1 homodimer and a STAT1/STAT3 heterodimer (Fig.
1A, right panel). These results
suggest that hypertonicity leads to a rapid activation of STAT factors
independent of the cell type used. However, the extent of stimulation
is different between these cell lines being most prominent in COS-7
cells. Therefore, these cells were used for the majority of the
experiments. To confirm that the observed STAT activation is due to the
hypertonic shock and not a specific result of sorbitol treatment, we
treated COS-7 cells with medium containing 300 mM NaCl,
which corresponds to a hyperosmolarity of 600 mosM. As
shown in Fig. 1B, in this case STAT1 is also activated after
15 min, although to a lesser extent than after treatment with
IL-6/sgp80 or sorbitol.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
Activation of STAT factors in different cell
lines by osmotic shock. A, HepG2, COS-7, and RMC cells
were treated with 600 mM sorbitol in the respective culture
medium for 15 min. Control cells received fresh medium. Cells were
harvested and nuclear extracts were prepared as described under
"Experimental Procedures." 5 µg of nuclear proteins were mixed
with a 32P-labeled oligonucleotide (mutated SIE probe of
the c-fos promoter 5'-GAT CCG GGA GGG ATT TAC GGG GAA ATG
CTG-3'), and EMSAs were performed. The DNA-protein complexes formed
were separated from the free probe by electrophoresis on a native 4.5%
polyacrylamide gel. The positions of comigrating STAT1 homodimer,
STAT1/STAT3 heterodimer, and STAT3 homodimer from IL-6 stimulated HepG2
cells are indicated by the arrows. B, COS-7 cells
were stimulated with either 300 mM NaCl, 600 mM
sorbitol, or 100 units/ml IL-6 plus 0.5 µg/ml sgp80 for 15 min. EMSAs
were performed as above.
|
|
The dose dependence of the STAT activation by hypertonicity in COS-7
cells is shown in Fig. 2A. At
200 mM sorbitol, a faint signal was observed, which became
prominent at 400 mM and reached a maximum at 600 mM (Fig. 2A). A typical time course demonstrates that the STAT activation was maximal at 30 min but was still detectable at 180 min (Fig. 2B). When a time-course experiment was
performed in HepG2 cells, it became apparent that in these cells both
STAT3 and STAT1 were activated, however with different kinetics (Fig. 2C). In the RMC cells, a similar time course of STAT factor
activation could be shown (Fig. 2D). We also tested STAT5a
after transient overexpression in COS-7 cells. However, this STAT
factor was not activated by osmotic stress, whereas after stimulation
with prolactin via cotransfected prolactin receptor a typical band
shift was detected (data not shown).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 2.
Dose and time dependence of STAT factor
activation in COS-7, HepG2, and RMC cells by osmotic shock.
A, COS-7 cells were treated with sorbitol in the indicated
doses for 15 min. Control cells only received fresh medium.
B, COS-7 cells were incubated with 600 mM
sorbitol for the times indicated. C and D, HepG2
cells (C) and RMC (D) were incubated with 600 mM sorbitol for the times indicated. EMSAs were performed
as described in the legend to Fig. 1.
|
|
Osmotic Shock Induces Nuclear Translocation of a STAT3/Green
Fluorescent Protein Chimera--
In order to study whether activation
of STATs via osmotic shock also results in their nuclear translocation,
we transiently expressed a STAT3/green fluorescent protein chimera in
HeLa cells. In control cells, a uniform staining of the cytoplasm and
nucleus was observed upon fluorescence microscopy (Fig.
3A). In contrast, in HeLa
cells that were stimulated with IL-6 and sgp80 or treated with
hyperosmotic medium for 30 min, an exclusive staining of the nuclei was
detected (Fig. 3, B and C). Thus, hyperosmolarity leads to a recruitment of STAT3 to the nucleus.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
Nuclear translocation of a STAT3/GFP chimera
after osmotic shock. HeLa cells were transfected with an
expression vector coding for a fusion protein of STAT3 and the green
fluorescent protein tagged to its C terminus. 72 h after
transfection, cells were either mock-stimulated (A) or
incubated for 30 min with 100 units/ml IL-6 plus 0.5 µg/ml sgp80
(B) or 600 mM sorbitol (C). Cells
were fixed and analyzed using an Nikon Eclipse E600TM
fluorescence microscope at a magnification of ×400.
|
|
Osmotic Shock Leads to the Tyrosine Phosphorylation of
STATs--
Activation of STATs usually requires phosphorylation of
specific tyrosine residues (Tyr-701 in STAT1 and Tyr-705 in STAT3), which then mediate the dimerization of STATs via neighboring Src homology 2 domains (39, 41). In order to demonstrate that osmotic shock
induces the tyrosine phosphorylation of STAT1, COS-7 cells were treated
with 600 mM sorbitol for different times and nuclear
extracts were prepared and analyzed by 10% SDS-PAGE. Proteins were
transferred to a PVDF membrane and incubated with an antiserum specific
for Tyr-701-phosphorylated STAT1. After osmotic shock, a protein
migrating at a position corresponding to STAT1 was detected (Fig.
4A). The extent of
phosphorylation correlates well with the DNA binding capacity shown in
Fig. 2B. In HepG2 cells, a similar phosphorylation pattern
was seen for STAT1 as well as for STAT3 (Fig. 4B). Note that
the phosphorylation of STAT3 precedes that of STAT1, which is also
reflected in the EMSA (Fig. 2C).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Tyrosine phosphorylation of STAT1 and STAT3
after osmotic shock. COS-7 (A) and HepG2
(B) cells were treated with 600 mM sorbitol in
the respective medium for the times indicated. Cells were harvested and
nuclear extracts were prepared as described under "Experimental
Procedures." 50 µg of nuclear proteins were separated by 10%
SDS-PAGE and blotted onto a PVDF membrane. Membranes were incubated
with phosphospecific STAT1 (Tyr-701) and phosphospecific STAT3
(Tyr-705) antibodies. Immunogenic proteins were visualized with the ECL
system. The positions of phosphorylated STAT1 (Tyr-701) and STAT3
(Tyr-705) are indicated by arrows.
|
|
Jak Kinases Are Involved in Signaling after Hypertonic
Shock--
The Jak1 kinase was demonstrated to be essential for the
Jak/STAT signaling via the IL-6 signal transducer gp130 (33). To find
out whether osmotic shock leads to an activation of Jak1, cell lysates
from COS-7 cells treated with 600 mM sorbitol for 15 min were immunoprecipitated with a Jak1-specific antiserum. Western blotting was performed with an phosphotyrosine-specific antibody and after stripping with an Jak1 antibody. Hypertonicity resulted in an increased Jak1 phosphorylation, which was almost as
prominent as after stimulation with IL-6/sgp80 (Fig.
5A). Interestingly, after
IL-6/sgp80 treatment, an additional band migrating at about 150 kDa was
coimmunoprecipitated. This band most likely corresponds to the
phosphorylated signal transducer gp130 to which Jak1 is constitutively
bound (data not shown). Phosphorylation of gp130, however, was hardly
detectable after osmotic shock. When gp130 was directly
immunoprecipitated from sorbitol- or IL-6-treated HepG2 cells,
the phosphotyrosine antiserum only detected gp130 in cells that were
stimulated with IL-6 (Fig. 5B). These data suggest that
activation of the Jak/STAT pathway by osmotic shock does not
require phosphorylation of gp130.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 5.
Tyrosine phosphorylation of Jak1 and the
signal transducer gp130 after osmotic shock. COS-7
(A) and HepG2 (B) cells were treated with either
600 mM sorbitol or 100 units/ml IL-6 plus 0.5 µg/ml sgp80
for 15 min. Cell lysates were prepared and immunoprecipitations with
anti-Jak1 (A) or anti-gp130 (B) antibodies were
performed as described under "Experimental Procedures."
Precipitated proteins were separated by 10% SDS-PAGE, blotted onto a
PVDF membrane, and analyzed by immunodetection with a specific
anti-phosphotyrosine antibody (A and B,
upper panel). Blots were stripped and reprobed with
anti-Jak1 (A) or anti-gp130 (B) antibodies for
verification of equal loading (A and B,
lower panel).
|
|
In order to assess whether also other Jak kinases are phosphorylated
upon hypertonic treatment, COS-7 and HepG2 cells were treated as above
and immunoprecipitations were performed with antisera against Jak2 and
Tyk2. Both kinases showed an increased tyrosine phosphorylation within
10 or 20 min after addition of sorbitol, although the Jak2 signal in
COS-7 cells was very faint (Fig. 6).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 6.
Tyrosine phosphorylation of Jak2 and Tyk2
after osmotic shock. COS-7 (A) and HepG2 (B)
cells were treated with 600 mM sorbitol in the respective
medium. Cell lysates were prepared and immunoprecipitations with either
anti-Jak2 or anti-Tyk2 antibodies were performed as described under
"Experimental Procedures." Precipitated proteins were separated by
10% SDS-PAGE, blotted onto a PVDF membrane, and analyzed by
immunodetection with a specific anti-phosphotyrosine antibody
(A and B, upper panel). Blots were
stripped and reprobed with either anti-Jak2 or anti-Tyk2
antibodies for verification of equal loading (A and
B, lower panel) as indicated.
|
|
To analyze whether the activation of Jaks is a prerequisite for STAT
activation by osmotic shock, we made use of the Jak1-deficient cell
line, U4A (33). Parental fibrosarcoma cells 2fTGH, U4A cells, and U4A
cells in which the Jak1 kinase has been stably reintroduced were
treated with sorbitol for 15 min, and nuclear extracts were analyzed in
an EMSA (Fig. 7A). In 2fTGH
cells, a prominent STAT1 activation was detected that was markedly
inhibited in Jak1-deficient cells. This was even more clearly seen when IL-6/sgp80 was used as a stimulus. Reconstitution of Jak1 in U4A cells
resulted in a cell line that upon stimulation with IL-6/sgp80 or
sorbitol displayed an enhanced STAT activation when compared with the
parental cells (Fig. 7). These findings suggest that Jak1 is involved
in STAT activation after osmotic shock. However, it does not seem to be
as essential as after IL-6 stimulation (33), inasmuch as in
Jak1-deficient cells a residual activation by sorbitol remained.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 7.
STAT factor activation after osmotic shock is
strongly dependent on Jak1 Kinase. A, 2fTGH, U4A, and
U4A-Jak1 cells were incubated with either 600 mM sorbitol
or 100 units/ml IL-6 plus 0.5 µg/ml sgp80 for 15 min. B,
2A, 2A-Jak2, U1A, and U1A-Tyk2 cells were incubated with 600 mM sorbitol for 15 min. EMSAs were performed as described
in the legend to Fig. 1.
|
|
We also analyzed 2A and U1A cells, which lack Jak2 and Tyk2,
respectively, and compared them with clones in which the respective kinase had been reconstituted (Fig. 7B) (33). In contrast to the Jak1-deficient cell line, 2A and U1A cells displayed a normal responsiveness to osmotic shock, suggesting that Jak2 and Tyk2 are not
crucial for STAT activation after hypertonicity.
Activation by Osmotic Shock of a Reporter Construct Containing STAT
Binding Sites--
In order to study whether activation of STATs by
osmotic shock also results in an increased gene activation, we made use
of a reporter construct p7xcore/tk/CAT in which an element containing seven identical STAT binding sites (the proximal core element of the
2-macroglobulin promoter) was cloned in front of the
basal thymidine kinase promoter followed by the chloramphenicol
acetyltransferase gene. A vector only containing the thymidine kinase
promoter (ptk/CAT) was used as a control. These constructs were
transiently expressed in HepG2 cells, and cells were treated with IL-6
or 600 mM sorbitol for 3 h after which reporter
activity was determined (Fig. 8). IL-6
stimulation of cells that were transfected with the p7xcore/tk/CAT construct resulted in an 4.6-fold increased CAT activity when compared
with ptk/CAT cells (Fig. 8). Osmotic shock resulted in a decrease to
about 25% of the basal reporter activity in ptk/CAT cells (data not
shown). However, in osmotically shocked p7xcore/tk/CAT cells, the
reporter activity was decreased to a much lesser extent resulting in a
relative induction of about 2.4-fold (Fig. 8). Thus, hyperosmotically
activated STATs are capable of transactivating a respective reporter
gene.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 8.
Hypertonically activated STATs transactivate
a reporter construct containing STAT binding sites. HepG2 cells
were transfected with the ptk/CAT and the p7xcore/tk/CAT construct,
respectively. After 24 h, cells were treated with 100 units/ml
IL-6 or 600 mM sorbitol for 3 h and processed for
reporter assays. CAT activities were normalized to -galactosidase
activities, and the ratio p7xcore/tk/CAT:ptk/CAT was calculated. The
data presented are the mean of six values obtained from three
independent experiments. The bars indicate the standard
deviation.
|
|
Hypertonicity-induced Cell Shrinkage Is Crucial for STAT
Activation--
In order to assess whether hyperosmolarity by itself
or the resultant cell shrinkage is the trigger for Jak/STAT activation, we increased the hypertonicity of the medium with 600 mM
urea, which is known to be a rapidly permeating solute that does not affect cell volume (42). When nuclear extracts from these cells were
analyzed in an EMSA, no STAT activation was detected (Fig. 9A). However, when these cells
were "super-induced" with either IL-6/sgp80 or increasing
concentrations of sorbitol again, a prominent STAT activation was seen
(Fig. 9B). From these results, we conclude that
hypertonicity itself is not sufficient for activation of the Jak/STAT
pathway and that urea does not inhibit STAT activation.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 9.
STAT activation is induced by cell shrinkage
but not by an increase in osmolarity. COS-7 cells were treated
with either 600 mM sorbitol or 600 mM urea for
15 min (A) or pretreated with 600 mM urea for 15 min and then incubated with increasing concentrations of sorbitol or
100 units/ml IL-6 plus 0.5 µg/ml sgp80 for another 15 min
(B). Nuclear extracts and EMSAs were performed as described
in the legend to Fig. 1. The positions of the activated STATs are
indicated by arrows.
|
|
 |
DISCUSSION |
In this study, we demonstrate that hyperosmotic shock activates
the Jak/STAT pathway. This pathway is known to mediate the signaling of
numerous cytokines, growth, and differentiation factors (19, 30). Thus,
we and others have recently shown that IL-6 activates three Jak
tyrosine kinases, namely Jak1, Jak2, and Tyk2, which then phosphorylate
the IL-6 signal transducer gp130 and the latent cytoplasmic
transcription factors STAT1 and STAT3 (43-45). Activated STAT factors
homo- and heterodimerize via an Src homology 2 domain/phosphotyrosine
interaction, are transported to the nucleus, and regulate gene
expression of IL-6-responsive genes, e.g. immediate early
and acute phase protein genes (36, 46-48).
In COS-7 cells, hypertonic treatment led to an activation of STAT1. In
contrast, in HepG2 and in RMC, both STAT1 and STAT3 were tyrosine
phosphorylated. This preference for certain STATs could be explained
either by different expression levels of STAT factors or by unknown
additional regulatory mechanisms (e.g. specific phosphatases) in these cells. Activation of STATs by osmotic shock is
not a general phenomenon since STAT5a was not activated even after
expression in COS-7 cells. In both COS-7 and HepG2 cells, all three
endogenous Jak kinases, Jak1, Jak2, and Tyk2, were
tyrosine-phosphorylated after hypertonic stress, although to a
different extent. Using cell lines deficient in one of the three
kinases, we could demonstrate that Jak1 is involved in STAT activation
upon stress, since in Jak1-negative U4A cells the STAT activation was
largely reduced. Restoration of Jak1 in these cells by overexpression
also restored and even enhanced the STAT1 signal. This was not observed
in Jak2-deficient 2A and Tyk2-deficient U1A cells, suggesting either
that these kinases do not play an important role or that they can
replace each other. Jak1 was also found to be crucial for activation of STAT1 and STAT3 after IL-6 and interferon- (33, 49).
Stress-activated STATs could stimulate gene transcription of reporter
gene constructs containing well characterized STAT1/3 binding sites as
enhancers. When compared with the activity of the basal thymidine
kinase promoter, both IL-6 and osmotic stress resulted in induction of
reporter gene activity. However, it should be pointed out that under
hypertonicity the basal CAT activity was strongly reduced. This could
be due to a general suppression of transcription and/or to an increased
degradation of the chloramphenicol acetyltransferase. An increased
protein catabolism after cell shrinkage was observed in several cell
systems (8).
Dimerization of surface receptors is currently believed to be the
trigger for activation of associated Jaks. However, we have no evidence
for an involvement of the signal transducer gp130 in the hyperosmotic
signal cascade since tyrosine phosphorylation of gp130 was absent after
osmotic shock. Thus, stress activation of the Jak/STAT is either
triggered by a mechanism located downstream of gp130 or other
cytokine/growth factor receptors are involved. Recently, it was shown
that hyperosmolarity and UV light lead to a clustering and
phosphorylation of the receptors for EGF, IL-1, and tumor necrosis
factor (18). The EGF receptor has been described to be an activator
of STAT1 and STAT3 (20, 39, 50), and EGF stimulates the
tyrosine-phosphorylation of Jak1, a function that is dependent on the
intrinsic kinase activity of the EGF receptor (41). However,
phosphorylation of STATs by EGF does not require Jak1 (51), and
therefore the EGF receptor is probably not involved in stress
activation of STATs.
It is currently unknown whether the initial trigger for activation of
intracellular signal cascades is the hyperosmolarity itself or the
resulting cell shrinkage. When COS-7 cells were treated with 600 mM urea, no STAT activation was observed. Since urea
readily diffuses into the cell, it does not lead to gross changes in
cell volume (42), although a slight shrinkage of liver parenchymal
cells due to opening of K+ channels in the plasma membrane
was observed (52). Thus, raising the intracellular osmolarity is
obviously not sufficient for signaling. Additionally, the pathways
leading to activation of JNKs and p38 were insensitive to hyper-osmotic
urea (53). However, addition of a non-permeating solute (600 mM sorbitol) or the IL-6/sgp80 complex to cells
equilibrated in 600 mM urea still resulted in a STAT
activation, suggesting that the cell shrinkage itself is the trigger
for Jak/STAT activation. In human neutrophils, osmotic cell shrinkage
induces tyrosine phosphorylation of several proteins and activation of
the Na+/H+ exchanger (42). In Chinese hamster
ovary cells, an osmotically induced decrease in cell volume resulted in
the tyrosine phosphorylation of three proteins of about 42, 85, and 120 kDa (54). The identity of the two larger proteins was not determined;
however, it is conceivable that they may represent a STAT factor and a
Jak kinase, respectively.
The physiological relevance of the activation of the Jak/STAT pathway
by osmotic stress is currently unknown. Jaks and STATs are involved in
the regulation of many important cellular processes such as growth and
differentiation, e.g. STAT3 is involved in the regulation of
several immediate early genes (jun-B, tis11) (46,
47), acute phase protein genes (36, 48) and the tissue inhibitor of
metalloproteinases-1 gene (55). Whether this transcriptional activation
triggers a program that is necessary for the adaptation of the cell to
the osmotic stress must be studied in the future.
 |
ACKNOWLEDGEMENTS |
We thank Wiltrud Frisch for technical
assistance and M. Robbertz for photographic work. Additionally, we
thank S. Thiel and A. Martens for their helpful discussion, and A. Ziemiecki (Bern) and J. Wijdenes (Besancon) for kindly providing us
with anti-Jak1/Jak2 and anti-gp130 antibodies, respectively.
 |
FOOTNOTES |
*
This work was supported by grants from the Deutsche
Forschungsgemeinschaft, by the Interdisciplinary Center for Clinical
Research in Biomaterials and Tissue-Material-Interaction in Implants
(BIOMAT), and by the Fonds der Chemischen Industrie.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Inst. of Biochemistry,
RWTH Aachen, Pauwelsstr. 30, 52057 Aachen, Germany. Tel.: 49-241-8088837; Fax: 49-241-8888428.
The abbreviations used are:
JNK, c-Jun
N-terminal kinase; CAT, chloramphenicol acetyltransferase; DMEM, Dulbecco's modified Eagle's medium; EGF, epidermal growth factor; EMSA, electrophoretic mobility shift assay; GFP, green fluorescent
protein; IL, interleukin; Jak, Janus kinase; PBS, phosphate-buffered
saline; PVDF, polyvinylidene difluoride; RMC, rat mesangial cells; PAGE, polyacrylamide gel electrophoresis; sgp80, soluble interleukin-6
receptor gp80; STAT, signal transducer and activator of transcription; TBS-N, Tris-buffered saline plus Nonidet P-40; tk, thymidine
kinase.
 |
REFERENCES |
-
Devary, Y.,
Gottlieb, R. A.,
Lau, L. F.,
and Karin, M.
(1991)
Mol. Cell. Biol.
11,
2804-2811[Abstract/Free Full Text]
-
Devary, Y.,
Gottlieb, R. A.,
Smeal, T.,
and Karin, M.
(1992)
Cell
71,
1081-1091[CrossRef][Medline]
[Order article via Infotrieve]
-
Derijard, B.,
Hibi, M.,
Wu, I. H.,
Barrett, T.,
Su, B.,
Deng, T.,
Karin, M.,
and Davis, R. J.
(1994)
Cell
76,
1025-1037[CrossRef][Medline]
[Order article via Infotrieve]
-
Devary, Y.,
Rosette, C.,
Di Donato, J. A.,
and Karin, M.
(1993)
Science
261,
1442-1445[Abstract/Free Full Text]
-
Schreck, R.,
Rieber, P.,
and Baeuerle, P. A.
(1991)
EMBO J.
10,
2247-2258[Medline]
[Order article via Infotrieve]
-
Koong, A. C.,
Chen, E. Y.,
Mivechi, N. F.,
Denko, N. C.,
Stambrook, P.,
and Giaccia, A. J.
(1994)
Cancer Res.
54,
5273-5279[Abstract/Free Full Text]
-
Burg, M. B.,
Kwon, E. D.,
and Kultz, D.
(1997)
Annu. Rev. Physiol.
59,
437-455[CrossRef][Medline]
[Order article via Infotrieve]
-
Häussinger, D.
(1996)
Biochem. J.
313,
697-710
-
Fischer, R.,
Schliess, F.,
and Häussinger, D.
(1997)
Glia
20,
51-58[CrossRef][Medline]
[Order article via Infotrieve]
-
Batiza, A. F.,
Schulz, T.,
and Masson, P. H.
(1996)
J. Biol. Chem.
271,
23357-23362[Abstract/Free Full Text]
-
Noe, B.,
Schliess, F.,
Wettstein, M.,
Heinrich, S.,
and Häussinger, D.
(1996)
Gastroenterology
110,
858-865[CrossRef][Medline]
[Order article via Infotrieve]
-
Schliess, F.,
Schreiber, R.,
and Häussinger, D.
(1995)
Biochem. J.
309,
13-17
-
Schliess, F.,
Sinning, R.,
Fischer, R.,
Schmalenbach, C.,
and Häussinger, D.
(1996)
Biochem. J.
320,
167-171
-
Sinning, R.,
Schliess, F.,
Kubitz, R.,
and Häussinger, D.
(1997)
FEBS Lett.
400,
163-167[CrossRef][Medline]
[Order article via Infotrieve]
-
Rouse, J.,
Cohen, P.,
Trigon, S.,
Morange, M.,
Alonso, L. A.,
Zamanillo, D.,
Hunt, T.,
and Nebreda, A. R.
(1994)
Cell
78,
1027-1037[CrossRef][Medline]
[Order article via Infotrieve]
-
Galcheva, G. Z.,
Derijard, B.,
Wu, I. H.,
and Davis, R. J.
(1994)
Science
265,
806-808[Abstract/Free Full Text]
-
Han, J.,
Lee, J. D.,
Bibbs, L.,
and Ulevitch, R. J.
(1994)
Science
265,
808-811[Abstract/Free Full Text]
-
Rosette, C.,
and Karin, M.
(1996)
Science
274,
1194-1197[Abstract/Free Full Text]
-
Darnell, J. E.
(1997)
Science
277,
1630-1635[Abstract/Free Full Text]
-
Fu, X. Y.,
and Zhang, J. J.
(1993)
Cell
74,
1135-1145[CrossRef][Medline]
[Order article via Infotrieve]
-
Vignais, M. L.,
Sadowski, H. B.,
Watling, D.,
Rogers, N. C.,
and Gilman, M.
(1996)
Mol. Cell. Biol.
16,
1759-1769[Abstract]
-
Silvennoinen, O.,
Schindler, C.,
Schlessinger, J.,
and Levy, D. E.
(1993)
Science
261,
1736-1739[Abstract/Free Full Text]
-
Meyer, D. J.,
Campbell, G. S.,
Cochran, B. H.,
Argetsinger, L. S.,
Larner, A. C.,
Finbloom, D. S.,
Carter,
Su, C.,
and Schwartz, J.
(1994)
J. Biol. Chem.
269,
4701-4704[Abstract/Free Full Text]
-
Schaper, F.,
Siewert, E.,
Gomez, L. M.,
Gatsios, P.,
Sachs, M.,
Birchmeier, W.,
Heinrich, P. C.,
and Castell, J.
(1997)
FEBS Lett.
405,
99-103[CrossRef][Medline]
[Order article via Infotrieve]
-
Gouilleux, F.,
Wakao, H.,
Mundt, M.,
and Groner, B.
(1994)
EMBO J.
13,
4361-4369[Medline]
[Order article via Infotrieve]
-
Gouilleux, F.,
Pallard, C.,
Dusanter, F. I.,
Wakao, H.,
Haldosen, L. A.,
Norstedt, G.,
Levy, D.,
and Groner, B.
(1995)
EMBO J.
14,
2005-2013[Medline]
[Order article via Infotrieve]
-
Bacon, C. M.,
Tortolani, P. J.,
Shimosaka, A.,
Rees, R. C.,
Longo, D. L.,
and O'Shea, J. J.
(1995)
FEBS Lett.
370,
63-68[CrossRef][Medline]
[Order article via Infotrieve]
-
Tortolani, P. J.,
Johnston, J. A.,
Bacon, C. M.,
McVicar, D. W.,
Shimosaka, A.,
Linnekin, D.,
Longo, D. L.,
and O'Shea, J. J.
(1995)
Blood
85,
3444-3451[Abstract/Free Full Text]
-
Kirito, K.,
Uchida, M.,
Yamada, M.,
Miura, Y.,
and Komatsu, N.
(1997)
J. Biol. Chem.
272,
16507-16513[Abstract/Free Full Text]
-
Pellegrini, S.,
and Dusanter-Fourt, I.
(1997)
Eur. J. Biochem.
248,
615-633[Medline]
[Order article via Infotrieve]
-
Arcone, R.,
Pucci, P.,
Zappacosta, F.,
Fontaine, V.,
Malorni, A.,
Marino, G.,
and Ciliberto, G.
(1991)
Eur. J. Biochem.
198,
541-547[Medline]
[Order article via Infotrieve]
-
Weiergräber, O.,
Hemmann, U.,
Küster, A.,
Müller-Newen, G.,
Schneider-Mergener, J.,
Rose-John, S.,
Kurschat, P.,
Brakenhoff, J. P.,
Hart, M. H.,
Stabel, S.,
and Heinrich, P. C.
(1995)
Eur. J. Biochem.
234,
661-669[Medline]
[Order article via Infotrieve]
-
Guschin, D.,
Rogers, N.,
Briscoe, J.,
Witthuhn, B.,
Watling, D.,
Horn, F.,
Pellegrini, S.,
Yasukawa, K.,
Heinrich, P.,
Stark, G. R.,
Ihle, J.,
and Kerr, I.
(1995)
EMBO J.
14,
1421-1429[Medline]
[Order article via Infotrieve]
-
Mertens, P. R.,
Harendza, S.,
Pollock, A. S.,
and Lovett, D. H.
(1997)
J. Biol. Chem.
272,
22905-22912[Abstract/Free Full Text]
-
Andrews, N. C.,
and Faller, D. V.
(1991)
Nucleic Acids Res.
19,
2499[Free Full Text]
-
Wegenka, U. M.,
Buschmann, J.,
Lütticken, C.,
Heinrich, P. C.,
and Horn, F.
(1993)
Mol. Cell. Biol.
13,
276-288[Abstract/Free Full Text]
-
Wagner, B. J.,
Hayes, T. E.,
Hoban, C. J.,
and Cochran, B. H.
(1990)
EMBO J.
9,
4477-4484[Medline]
[Order article via Infotrieve]
-
Seed, B.,
and Sheen, J.
(1988)
Gene (Amst.)
67,
271-277[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhong, Z.,
Wen, Z.,
and Darnell, J. J.
(1994)
Science
264,
95-98[Abstract/Free Full Text]
-
Gerhartz, C.,
Heesel, B.,
Sasse, J.,
Hemmann, U.,
Landgraf, C.,
Schneider-Mergener, J.,
Horn, F.,
Heinrich, P. C.,
and Graeve, L.
(1996)
J. Biol. Chem.
271,
12991-12998[Abstract/Free Full Text]
-
Shual, K.,
Ziemiecki, A.,
Wilks, A. F.,
Harpur, A. G.,
Sadowski, H. B.,
Gilman, M. Z.,
and Darnell, J. E.
(1993)
Nature
366,
580-583[CrossRef][Medline]
[Order article via Infotrieve]
-
Krump, E.,
Nikitas, K.,
and Grinstein, S.
(1997)
J. Biol. Chem.
272,
17303-17311[Abstract/Free Full Text]
-
Lütticken, C.,
Wegenka, U. M.,
Yuan, J.,
Buschmann, J.,
Schindler, C.,
Ziemiecki, A.,
Harpur, A. G.,
Wilks, A. F.,
Yasukawa, K.,
Taga, T.,
Kishimoto, T.,
Barbieri, G.,
Pellegrini, S.,
Sendtner, M.,
Heinrich, P. C.,
and Horn, F.
(1994)
Science
263,
89-92[Abstract/Free Full Text]
-
Stahl, N.,
Boulton, T. G.,
Farruggella, T.,
Ip, N. Y.,
Davis, S.,
Witthuhn, B. A.,
Quelle, F. W.,
Silvennoinen, O.,
Barbieri, G.,
Pellegrini, S.,
Ihle, J. N.,
and Yancopoulos, G. D.
(1994)
Science
263,
92-95[Abstract/Free Full Text]
-
Narazaki, M.,
Witthuhn, B. A.,
Yoshida, K.,
Silvennoinen, O.,
Yasukawa, K.,
Ihle, J. N.,
Kishimoto, T.,
and Taga, T.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2285-2289[Abstract/Free Full Text]
-
Lord, K. A.,
Abdollahi, A.,
Thomas, S. M.,
DeMarco, M.,
Brugge, J. S.,
Hoffman, L. B.,
and Liebermann, D. A.
(1991)
Mol. Cell. Biol.
11,
4371-4379[Abstract/Free Full Text]
-
Nakajima, K.,
and Wall, R.
(1991)
Mol. Cell. Biol.
11,
1409-1418[Abstract/Free Full Text]
-
Yuan, J.,
Wegenka, U. M.,
Lütticken, C.,
Buschmann, J.,
Decker, T.,
Schindler, C.,
Heinrich, P. C.,
and Horn, F.
(1994)
Mol. Cell. Biol.
14,
1657-1668[Abstract/Free Full Text]
-
Briscoe, J.,
Rogers, N. C.,
Witthuhn, B. A.,
Watling, D.,
Harpur, A. G.,
Wilks, A. F.,
Stark, G. R.,
Ihle, J. N.,
and Kerr, I. M.
(1996)
EMBO J.
15,
799-809[Medline]
[Order article via Infotrieve]
-
Ruff-Jamison, J. S.,
Zhong, Z.,
Wen, Z.,
Chen, K.,
Darnell, J. E.,
and Cohen, S.
(1994)
J. Biol. Chem.
269,
21933-21935[Abstract/Free Full Text]
-
Leaman, D. W.,
Pisharody, S.,
Flickinger, T. W.,
Commane, M. A.,
Schlessinger, J.,
Kerr, I. M.,
Levy, D. E.,
and Stark, G. R.
(1996)
Mol. Cell. Biol.
16,
369-375[Abstract]
-
Hallbrucker, C.,
vom, D. S.,
Ritter, M.,
Lang, F.,
and Häussinger, D.
(1994)
Pflügers Arch.
428,
552-560[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhang, Z.,
and Cohen, D. M.
(1996)
Am. J. Physiol.
271,
F1234-F1238[Abstract/Free Full Text]
-
Szaszi, K.,
Buday, L.,
and Kapus, A.
(1997)
J. Biol. Chem.
272,
16670-16678[Abstract/Free Full Text]
-
Bugno, M.,
Graeve, L.,
Gatsios, P.,
Koj, A.,
Heinrich, P. C.,
Travis, J.,
and Kordula, T.
(1995)
Nucleic Acids Res.
23,
5041-5047[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Araki, J. Langenick, M. Gamper, R. A. Firtel, and J. G. Williams
Evidence that DIF-1 and hyper-osmotic stress activate a Dictyostelium STAT by inhibiting a specific protein tyrosine phosphatase
Development,
April 1, 2008;
135(7):
1347 - 1353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva
Cellular Response to Hyperosmotic Stresses
Physiol Rev,
October 1, 2007;
87(4):
1441 - 1474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lopez-Bojorquez, P. Villalobos, C. Garcia-G., A. Orozco, and C. Valverde-R.
Functional identification of an osmotic response element (ORE) in the promoter region of the killifish deiodinase 2 gene (FhDio2)
J. Exp. Biol.,
September 1, 2007;
210(17):
3126 - 3132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Y. Tong, J.-J. Guo, A.-L. Huang, H. Liu, C.-D. Hu, S. S. M. Chung, and B. C. B. Ko
Regulation of Nucleocytoplasmic Trafficking of Transcription Factor OREBP/TonEBP/NFAT5
J. Biol. Chem.,
August 18, 2006;
281(33):
23870 - 23879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sheikh-Hamad and M. C. Gustin
MAP kinases and the adaptive response to hypertonicity: functional preservation from yeast to mammals
Am J Physiol Renal Physiol,
December 1, 2004;
287(6):
F1102 - F1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|